- Home
- NSA vs MIRM Comparison
NSA vs MIRM Comparison
Compare NSA & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- MIRM
- Stock Information
- Founded
- NSA 2013
- MIRM 2018
- Country
- NSA United States
- MIRM United States
- Employees
- NSA N/A
- MIRM N/A
- Industry
- NSA Real Estate Investment Trusts
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- MIRM Health Care
- Exchange
- NSA Nasdaq
- MIRM Nasdaq
- Market Cap
- NSA 2.8B
- MIRM 2.2B
- IPO Year
- NSA 2015
- MIRM 2019
- Fundamental
- Price
- NSA $34.63
- MIRM $45.97
- Analyst Decision
- NSA Hold
- MIRM Strong Buy
- Analyst Count
- NSA 10
- MIRM 12
- Target Price
- NSA $40.83
- MIRM $63.17
- AVG Volume (30 Days)
- NSA 992.7K
- MIRM 397.1K
- Earning Date
- NSA 05-05-2025
- MIRM 05-07-2025
- Dividend Yield
- NSA 6.62%
- MIRM N/A
- EPS Growth
- NSA N/A
- MIRM N/A
- EPS
- NSA 0.12
- MIRM N/A
- Revenue
- NSA $742,357,000.00
- MIRM $379,251,000.00
- Revenue This Year
- NSA N/A
- MIRM $33.98
- Revenue Next Year
- NSA $3.75
- MIRM $16.19
- P/E Ratio
- NSA $284.16
- MIRM N/A
- Revenue Growth
- NSA N/A
- MIRM 69.31
- 52 Week Low
- NSA $30.88
- MIRM $23.83
- 52 Week High
- NSA $49.44
- MIRM $54.23
- Technical
- Relative Strength Index (RSI)
- NSA 44.68
- MIRM 61.24
- Support Level
- NSA $33.60
- MIRM $43.30
- Resistance Level
- NSA $34.33
- MIRM $44.57
- Average True Range (ATR)
- NSA 0.93
- MIRM 1.25
- MACD
- NSA -0.10
- MIRM 0.02
- Stochastic Oscillator
- NSA 32.26
- MIRM 83.70
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.